
Sign up to save your podcasts
Or


Episode Summary:
He outlines which inspections are still taking place, which types of products are being prioritized, and how the shutdown impacts imported goods ranging from foods and drugs to cosmetics and medical devices. Benjamin also discusses how companies can manage communication delays with the FDA and Customs, what steps importers should take if their products are detained, and what to expect when the government eventually reopens.
Key Timestamps:
Show Description:
He highlights how FDA inspectors prioritize higher-risk imports, such as ready-to-eat foods and seafood potentially contaminated with Cesium-137, while lower-risk products like cosmetics and animal food experience fewer inspections. Benjamin also discusses how the FDA’s risk-based matrix determines where limited resources are allocated and how Customs continues to perform mandatory inspections.
For importers and manufacturers, Benjamin offers guidance on managing delays, communicating effectively with regulators, and ensuring compliance while operations are slowed. He warns that once the government reopens, backlogs and staffing shortages will likely extend delays for weeks or months. His advice emphasizes staying proactive, maintaining contact with compliance officers, and seeking experienced regulatory support to navigate the challenges.
By fdaimportsbenjaminenglandEpisode Summary:
He outlines which inspections are still taking place, which types of products are being prioritized, and how the shutdown impacts imported goods ranging from foods and drugs to cosmetics and medical devices. Benjamin also discusses how companies can manage communication delays with the FDA and Customs, what steps importers should take if their products are detained, and what to expect when the government eventually reopens.
Key Timestamps:
Show Description:
He highlights how FDA inspectors prioritize higher-risk imports, such as ready-to-eat foods and seafood potentially contaminated with Cesium-137, while lower-risk products like cosmetics and animal food experience fewer inspections. Benjamin also discusses how the FDA’s risk-based matrix determines where limited resources are allocated and how Customs continues to perform mandatory inspections.
For importers and manufacturers, Benjamin offers guidance on managing delays, communicating effectively with regulators, and ensuring compliance while operations are slowed. He warns that once the government reopens, backlogs and staffing shortages will likely extend delays for weeks or months. His advice emphasizes staying proactive, maintaining contact with compliance officers, and seeking experienced regulatory support to navigate the challenges.